UNSPSC 51162306: Acetaminophen/caffeine/chlorpheniramine/phenylpropanolamine
Commodity
Code facts
- Part of
-
-
51000000
-
51160000
- 51162300
-
51160000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51162306
Definition
This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.
The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.
Read the full definition
The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification.
The second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula C8H10N4O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3G6A5W338E, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears U.S. National Institutes of Health Compound Identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate.
The European Medicines Agency schedules Caffeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13146MIG. The World Health Organization schedules caffeine in its Anatomical Therapeutic Chemical (ATC) Classification. The third component of this combination drug is a histamine-1 receptor antagonist, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3U6IO1965U.
The European Medicines Agency schedules Chlorphenamine (under maleate form) in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01243MIG. Chlorpheniramine generally arises in the molecular formula C16H19ClN2. The term 'chlorpheniramine maleate' is a European Pharmacopoeia designation.
The fourth componeny of this combination drug is an adrenergic agonist with the molecular formula C9H13NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 33RU150WUN, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears U.S. National Institutes of Health Compound Identifier 4786. The European Medicines Agency schedules Phenylpropanolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09790MIG.
The term PHENYLPROPANOLAMINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). The World Health Organization schedules phenylpropanolamine in its Anatomical Therapeutic Chemical (ATC) Classification.
About UNSPSC 51162306
UNSPSC 51162306 Acetaminophen/caffeine/chlorpheniramine/phenylpropanolamine is a Commodity code that in practice covers state and local procurement of generic pharmaceuticals and over-the-counter health products, including naloxone and drug deactivation systems, distributed through county health departments and multistate cooperative purchasing alliances to support community health and emergency response initiatives. State and local governments procure under this code through county health agencies and statewide cooperative purchasing consortia that aggregate demand across multiple jurisdictions and authorized pharmaceutical wholesalers. Purchases are typically made on fixed-fee or competitive-pricing bases with quarterly or as-needed delivery schedules, compliance requirements including cGMP and Drug Supply Chain Security Act certification, and contractual relationships with established pharmaceutical distributors.
Recent activity spans Florida and a multistate regional group anchored in Minnesota. Seminole County, Florida released IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and a two-year initial term with one-year renewal option. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, with responses due March 26, 2026 and awarded vendors to be effective July 1, 2026. Both opportunities require vendors to maintain comprehensive insurance coverage, certify drug supply chain compliance, and provide detailed product information including National Drug Codes and packaging specifications.
Quick answers
What is UNSPSC 51162306?
UNSPSC 51162306 is Acetaminophen/
Which NIGP codes match UNSPSC 51162306?
UNSPSC 51162306 maps to 1 NIGP code, 26948 Expectorants, Antitussives, and Mucolytic Agents.
On GovTribe
See everything under UNSPSC 51162306
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code